Search for: "ACTAVIS, INC."
Results 201 - 220
of 382
Sort by Relevance
|
Sort by Date
12 Dec 2013, 7:12 am
In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
22 Nov 2013, 2:40 pm
Actavis, Inc., et al., C.A. [read post]
17 Nov 2013, 8:56 pm
• Defendants: Watson Laboratories Inc; Actavis, Inc.; Actavis Pharma, Inc. [read post]
4 Nov 2013, 1:42 pm
Avanir Pharmaceuticals, Inc., et al. v. [read post]
17 Oct 2013, 11:09 am
In Pandora Media, Inc. v. [read post]
17 Oct 2013, 5:00 am
Monier, Inc., a UCL/CLRA trial that went to verdict earlier this year. [read post]
11 Oct 2013, 9:34 pm
Meuth, Associate General Counsel, Intellectual Property for Eisai Inc.; Kelly L. [read post]
22 Aug 2013, 1:34 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals, which is now known as Actavis, Inc. [read post]
29 Jul 2013, 5:00 am
Cotter, University of Minnesota Law School asks FTC v Actavis, Inc: When is the Rule of Reason Not the Rule of Reason? [read post]
11 Jul 2013, 7:37 am
Actavis. [read post]
1 Jul 2013, 9:59 pm
Actavis, Inc. and Mutual Pharmaceutical Co. v. [read post]
30 Jun 2013, 10:03 pm
Actavis, Inc., No. 12-416 (U.S. [read post]
25 Jun 2013, 9:51 am
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
25 Jun 2013, 6:52 am
Last week, in Federal Trade Commission v Actavis Inc. et Al., the US Supreme Court turned its attention to a fascinating crossroad of IP and competition law, reverse payment settlements. [read post]
24 Jun 2013, 10:08 am
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
24 Jun 2013, 6:08 am
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
23 Jun 2013, 8:50 pm
• Defendants: Par Pharmaceutical Inc.; Actavis Elizabeth LLC; Actavis Inc. [read post]
21 Jun 2013, 12:56 pm
Actavis, the Court held, in a five-to-three decision by Justice Breyer (Justice Alito was recused), that antitrust lawsuits challenging so-called “reverse payments” may proceed. [read post]
20 Jun 2013, 1:00 am
Actavis, Inc., the Supreme Court held that reverse payment (“pay-for-delay”) settlement agreements made in the context of settling Hatch-Waxman ANDA litigation should be evaluated for antitrust violations under a “rule of reason” analysis. [read post]
